Interaction between oxidative stress and smoking is associated with an increased risk of rheumatoid arthritis: A case-control study

Rheumatology (United Kingdom)

Volumn 52, Issue 3, 2013, Pages 487-493

  Navarro Compán, Victoria ^a   Melguizo Madrid, Enrique ^a   Hernández Cruz, Blanca ^a   Santos Rey, Koldo ^a   Leyva Prado, Christian ^a   González Martín, Carmen ^a   Navarro Sarabia, Federico ^a   González Rodríguez, Concepción ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Oxidative stress; Rheumatoid arthritis; Smoking

Indexed keywords

C REACTIVE PROTEIN; CARBONYL PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; MALONALDEHYDE; PROTEIN; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; URIC ACID BLOOD LEVEL;

ADULT; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, HDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RISK; SMOKING; URIC ACID;

EID: 84874075103     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes286     Document Type: Article

References (38)

1. Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009;4:417-34.
2. De Rycke L, Peene I, Hoffman IE et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587-93.
3. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004;50:3476-84.
4. Uhlig T, Hagen KB, Kvien TK. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol 1999;26:47-54.
5. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659-72.
6. Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2006;2:425-33.
7. Kä llberg H, Padyukov L, Plenge RM et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007;80:867-75.
8. Linn-Rasker SP, van der Helm-van Mil AHM, van Gaalen FA et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DR1 shared epitope alleles. Ann Rheum Dis 2006;65:366-71.
9. Kä llberg B, Padyukov L, Bengtusson C et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011;70:508-11.
10. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH et al. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Arthritis Rheum 2007;56:2913-8.
11. Cedergren J, Forslund T, Sundqvist T, Skogh T. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Rheumatol 2007;34:2162-70.
12. Valko M, Leibfritz D, Moncola J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
13. Seven A, Gü zel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008;41:538-43.
14. Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 2000;19:275-7.
15. Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008;152:415-22.
16. Mazor D, Greenberg L, Shamir D, Meyerstein D, Meyerstein N. Antioxidant properties of bucillamine: possible mode of action. Biochem Biophys Res Commun 2006;349:1171-5.
17. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-78.
18. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006;15:737-45.
19. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50: 3085-92.
20. Zhang R, Brennan ML, Shen Z et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002;277:46116-22.
21. Mihaljevic B, Katusin-Razem B, Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 1996;21:53-63.
22. Levine RL, Wehr N, Williams JA, Stadtman ER, Shacter E. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 2000;99:15-24.
23. De Mutsert R, Jager KJ, Zoccali C, Dekker FW. The effect of joint exposures: examining the presence of interaction. Kidney Int 2009;75:677-81.
24. Carlens C, Hergens MP, Grunewald J et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010;181:1217-22.
25. Heliövaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
26. Wruck CJ, Fragoulis A, Gurzynski A et al. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 2011;70:844-50.
27. Coaccioli S, Panaccione A, Biondi R et al. Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis. Clin Ter 2009;160:467-72.
28. Criswell LA, Saag KG, Mikuls TR et al. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis 2006;65:1163-7.
29. Desai PB, Manjunath S, Kadi S, Chetana K, Vanishree J. Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. Eur Rev Med Pharmacol Sci 2010;14:959-67.
30. Vasanthi P, Nalini G, Rajasekhar G. Status of oxidative stress in rheumatoid arthritis. Int J Rheum Dis 2009;12: 29-33.
31. Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol 2007;26:64-8.
32. Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 2011;216:1010-17.
33. Pemberton PW, Ahmad Y, Bodill H et al. Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. BMC Res Notes 2009;2:83-9.
34. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-23.
35. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian OG, Borderie D. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 2006;372:147-53.
36. Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. Appl Toxicol 2001; 21:69-73.
37. Isik A, Koca SS, Ustundag B, Celik H, Yildirim A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007;26:342-48.
38. Karlson EW, Chang SC, Cui J et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010;69:54-60.